Product Details for ANDA 216321
POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)
10MEQ
Marketing Status: Prescription
15MEQ
Marketing Status: Prescription
20MEQ
Marketing Status: Prescription
10MEQ
Marketing Status: Prescription
Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 10MEQ
Reference Listed Drug: No
Reference Standard: No
TE Code: AB1
Application Number: A216321
Product Number: 001
Approval Date: Jun 16, 2023
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 10MEQ
Reference Listed Drug: No
Reference Standard: No
TE Code: AB1
Application Number: A216321
Product Number: 001
Approval Date: Jun 16, 2023
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
15MEQ
Marketing Status: Prescription
Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 15MEQ
Reference Listed Drug: No
Reference Standard: No
TE Code: AB1
Application Number: A216321
Product Number: 002
Approval Date: Jun 16, 2023
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 15MEQ
Reference Listed Drug: No
Reference Standard: No
TE Code: AB1
Application Number: A216321
Product Number: 002
Approval Date: Jun 16, 2023
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
20MEQ
Marketing Status: Prescription
Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 20MEQ
Reference Listed Drug: No
Reference Standard: No
TE Code: AB1
Application Number: A216321
Product Number: 003
Approval Date: Jun 16, 2023
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 20MEQ
Reference Listed Drug: No
Reference Standard: No
TE Code: AB1
Application Number: A216321
Product Number: 003
Approval Date: Jun 16, 2023
Applicant Holder Full Name: RUBICON RESEARCH PRIVATE LTD
Marketing Status: Prescription
Patent and Exclusivity Information